Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
-
Published:2022-12
Issue:
Volume:66
Page:157-161
-
ISSN:0960-9776
-
Container-title:The Breast
-
language:en
-
Short-container-title:The Breast
Author:
Del Re Marzia,
Crucitta Stefania,
Omarini Claudia,
Bargagna Irene,
Mongillo Marta,
Palleschi Michela,
Stucci Stefania,
Meattini Icro,
D'Onofrio Raffaella,
Lorenzini Giulia,
Biondani Pamela,
De Giorgi Ugo,
Porta Camillo,
Livi Lorenzo,
Natalizio Salvatore,
Fontana Andrea,
Giontella Elena,
Angelini Lucia,
Fogli StefanoORCID,
Danesi Romano
Funder
Novartis
Astellas Pharma US
Sanofi
AstraZeneca
Janssen Pharmaceuticals
Bristol-Myers Squibb
Merck Sharp and Dohme
Pfizer
Ipsen
Bayer
Subject
General Medicine,Surgery
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献